equol has been researched along with Glucose Intolerance in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheong, SH; Furuhashi, K; Ito, K; Miura, Y; Nagaoka, M; Yagasaki, K; Yonezawa, T | 1 |
Beydoun, HA; Jeng, HA; Kantaria, K | 1 |
2 other study(ies) available for equol and Glucose Intolerance
Article | Year |
---|---|
Antihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Blood Glucose; Cell Line; Chemokine CCL2; Cholesterol; Diabetes Mellitus, Type 2; Equol; Glucose Intolerance; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle Cells; Muscle Fibers, Skeletal; Phosphorylation; Rats; Thiobarbituric Acid Reactive Substances; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Urinary phytoestrogens in relation to metabolic disturbances among children and adolescents.
Topics: Adolescent; Blood Glucose; Blood Pressure; Body Mass Index; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Dyslipidemias; Equol; Genistein; Glucose; Glucose Intolerance; Humans; Lipid Metabolism; Phytoestrogens; Triglycerides | 2015 |